Time New York: Sun 17 Dec 20:26 pm  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Galectin Therapeutics (GALT) in Focus: Stock Moves 6.5% Higher

Zacks

Galectin Therapeutics, Inc. GALT was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 61.6% in the past one-month time frame.

The company has seen a mixed track record when it comes to estimate revisions of no increase and decrease over the past few weeks, while the Zacks Consensus Estimate for the current quarter hasn’t been in a trend either. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Galectin Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Galectin Therapeutics Inc. Price


A better-ranked stock in the Medical sector is MEI Pharma, Inc. MEIP, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is GALT going up? Or down? Predict to see what others think: Up or Down

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.